Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.38% | 45.24% | 56.80% | 71.25% | 82.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.38% | 45.24% | 56.80% | 71.25% | 82.18% |
| Cost of Revenue | 6.32% | 8.78% | 27.41% | 56.01% | 67.87% |
| Gross Profit | 6.43% | 92.07% | 93.12% | 88.75% | 97.29% |
| SG&A Expenses | 160.12% | 74.81% | 41.91% | -2.04% | -16.73% |
| Depreciation & Amortization | 9.62% | -52.56% | -32.81% | -8.65% | 15.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.01% | 26.92% | 33.89% | 35.83% | 34.72% |
| Operating Income | -65.70% | 124.41% | 172.37% | 286.03% | 431.39% |
| Income Before Tax | -64.64% | 153.63% | 750.48% | 5,229.88% | 1,292.00% |
| Income Tax Expenses | -68.23% | 82.50% | 140.04% | 217.05% | 473.41% |
| Earnings from Continuing Operations | -63.21% | 199.82% | 10,364.38% | 743.32% | 633.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.21% | 199.82% | 10,364.38% | 743.32% | 633.58% |
| EBIT | -65.70% | 124.41% | 172.37% | 286.03% | 431.39% |
| EBITDA | -64.01% | 110.59% | 154.82% | 253.62% | 374.28% |
| EPS Basic | -63.62% | 171.51% | 9,831.58% | 808.10% | 671.52% |
| Normalized Basic EPS | -66.43% | 116.22% | 203.31% | 350.58% | 556.03% |
| EPS Diluted | -63.62% | 171.51% | 9,831.58% | 808.10% | 671.52% |
| Normalized Diluted EPS | -66.43% | 116.22% | 203.31% | 350.58% | 556.03% |
| Average Basic Shares Outstanding | -4.88% | 8.90% | -2.15% | 9.27% | 9.27% |
| Average Diluted Shares Outstanding | -4.88% | 8.90% | -2.15% | 9.27% | 9.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |